These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19781924)

  • 1. Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans.
    Fielden MR; Hassani M; Uppal H; Day-Lollini P; Button D; Martin RS; Garrido R; Liu X; Kolaja KL
    Exp Toxicol Pathol; 2010 Nov; 62(6):607-13. PubMed ID: 19781924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.
    Elangbam CS; Job LE; Zadrozny LM; Barton JC; Yoon LW; Gates LD; Slocum N
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):253-62. PubMed ID: 18511249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glycosaminoglycans content and 5-hydroxytryptamine 2B receptor in the heart valves of Sprague-Dawley rats with spontaneous mitral valvulopathy--a possible exacerbation by dl-amphetamine sulfate in Fischer 344 rats?
    Elangbam CS; Wehe JG; Barton JC; Krull DL; Nyska A; Crabbs T; Kissling GE
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):89-99. PubMed ID: 16996724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
    Rajamannan NM; Caplice N; Anthikad F; Sebo TJ; Orszulak TA; Edwards WD; Tajik J; Schwartz RS
    J Heart Valve Dis; 2001 Nov; 10(6):827-31. PubMed ID: 11767194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats.
    Elangbam CS; Lightfoot RM; Yoon LW; Creech DR; Geske RS; Crumbley CW; Gates LD; Wall HG
    J Histochem Cytochem; 2005 May; 53(5):671-7. PubMed ID: 15872060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy.
    Cavero I; Guillon JM
    J Pharmacol Toxicol Methods; 2014; 69(2):150-61. PubMed ID: 24361689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic drugs and valvular heart disease.
    Rothman RB; Baumann MH
    Expert Opin Drug Saf; 2009 May; 8(3):317-29. PubMed ID: 19505264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
    Setola V; Hufeisen SJ; Grande-Allen KJ; Vesely I; Glennon RA; Blough B; Rothman RB; Roth BL
    Mol Pharmacol; 2003 Jun; 63(6):1223-9. PubMed ID: 12761331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced valvulopathy: an update.
    Elangbam CS
    Toxicol Pathol; 2010 Oct; 38(6):837-48. PubMed ID: 20716786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term serotonin administration induces heart valve disease in rats.
    Gustafsson BI; Tømmerås K; Nordrum I; Loennechen JP; Brunsvik A; Solligård E; Fossmark R; Bakke I; Syversen U; Waldum H
    Circulation; 2005 Mar; 111(12):1517-22. PubMed ID: 15781732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependency and reversibility of serotonin-induced valvular heart disease in rats.
    Droogmans S; Roosens B; Cosyns B; Degaillier C; Hernot S; Weytjens C; Garbar C; Caveliers V; Pipeleers-Marichal M; Franken PR; Bossuyt A; Schoors D; Lahoutte T; Van Camp G
    Cardiovasc Toxicol; 2009 Sep; 9(3):134-41. PubMed ID: 19609730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY; Chung EJ; Park SW; Lee WY
    Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations.
    Papoian T; Jagadeesh G; Saulnier M; Simpson N; Ravindran A; Yang B; Laniyonu AA; Khan I; Szarfman A
    Toxicol Pathol; 2017 Apr; 45(3):381-388. PubMed ID: 28421966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine use and the risk of valvular heart disease.
    Tan LC; Ng KK; Au WL; Lee RK; Chan YH; Tan NC
    Mov Disord; 2009 Feb; 24(3):344-9. PubMed ID: 18989898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
    Kelly CR; Sharif NA
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.